🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/11/1997 | 56,14 | 56,14 | 54,74 | 54,74 | -2,50% | 2,50% | 25.381 |
| 10/11/1997 | 55,68 | 56,85 | 54,98 | 56,14 | +3,00% | 3,36% | 37.671 |
| 07/11/1997 | 52,87 | 55,68 | 51,93 | 54,51 | -3,32% | 7,08% | 38.632 |
| 06/11/1997 | 56,61 | 57,55 | 56,14 | 56,38 | -1,23% | 2,48% | 28.026 |
| 05/11/1997 | 56,85 | 58,02 | 56,14 | 57,08 | +1,24% | 3,29% | 52.472 |
| 04/11/1997 | 57,78 | 57,78 | 55,91 | 56,38 | -2,43% | 3,24% | 47.956 |
| 03/11/1997 | 56,14 | 58,48 | 55,21 | 57,78 | +5,56% | 5,83% | 40.422 |
| 31/10/1997 | 56,14 | 58,48 | 54,74 | 54,74 | -0,85% | 6,67% | 88.459 |
| 30/10/1997 | 55,21 | 56,61 | 53,81 | 55,21 | -1,67% | 5,08% | 56.185 |
| 29/10/1997 | 57,55 | 58,02 | 55,21 | 56,14 | +1,69% | 4,88% | 61.528 |
| 28/10/1997 | 51,00 | 56,38 | 50,53 | 55,21 | +6,79% | 11,47% | 175.502 |
| 27/10/1997 | 55,21 | 55,21 | 50,53 | 51,70 | -7,92% | 8,47% | 179.563 |
| 24/10/1997 | 61,76 | 61,76 | 55,68 | 56,14 | -7,69% | 9,85% | 81.085 |
| 23/10/1997 | 60,36 | 61,76 | 58,48 | 60,82 | -1,89% | 5,43% | 111.676 |
| 22/10/1997 | 63,16 | 63,63 | 61,76 | 61,99 | -2,21% | 2,96% | 66.391 |
| 21/10/1997 | 62,23 | 63,63 | 61,76 | 63,40 | +2,65% | 3,01% | 165.937 |
| 20/10/1997 | 64,10 | 64,57 | 58,02 | 61,76 | +2,72% | 10,22% | 236.122 |
| 17/10/1997 | 64,57 | 64,57 | 58,72 | 60,12 | -7,55% | 9,06% | 95.004 |
| 16/10/1997 | 67,37 | 68,78 | 64,57 | 65,03 | -4,47% | 6,25% | 82.982 |
| 15/10/1997 | 68,08 | 68,78 | 67,84 | 68,08 | -0,68% | 1,37% | 57.681 |
| 14/10/1997 | 66,67 | 68,78 | 65,97 | 68,54 | +3,53% | 4,21% | 103.874 |
| 13/10/1997 | 64,57 | 67,37 | 64,57 | 66,20 | +2,17% | 4,35% | 78.387 |
| 10/10/1997 | 65,50 | 65,97 | 64,57 | 64,80 | -1,77% | 2,14% | 36.308 |
| 09/10/1997 | 64,33 | 66,91 | 63,63 | 65,97 | +2,55% | 5,09% | 54.796 |
| 08/10/1997 | 65,50 | 66,91 | 62,69 | 64,33 | -0,36% | 6,43% | 108.790 |
| 07/10/1997 | 62,23 | 67,37 | 61,76 | 64,57 | +4,15% | 9,02% | 196.982 |
| 06/10/1997 | 61,29 | 62,69 | 61,29 | 61,99 | -0,38% | 2,29% | 35.480 |
| 03/10/1997 | 60,82 | 62,23 | 59,89 | 62,23 | +2,70% | 3,85% | 51.910 |
| 02/10/1997 | 61,29 | 61,29 | 59,89 | 60,59 | -0,77% | 2,29% | 14.480 |
| 01/10/1997 | 61,76 | 62,23 | 59,89 | 61,06 | -1,14% | 3,79% | 34.010 |